Cingulate Inc

CING
1,12
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:52:58
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
26/2/202413:00EDGAR2Form 8-K - Current report
14/2/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202412:50EDGAR2Form 8-K - Current report
13/2/202412:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
09/2/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202412:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202422:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
05/2/202423:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202415:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202423:01EDGAR2Form SC 13D/A - General statement of acquisition of..
29/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:59EDGAR2Form S-1/A - General form for registration of securities..
29/1/202414:05EDGAR2Form 8-K - Current report
29/1/202414:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202412:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
12/1/202423:03EDGAR2Form S-1 - General form for registration of securities under..
04/1/202423:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202312:02EDGAR2Form 8-K - Current report
15/12/202314:55EDGAR2Form 8-K - Current report
12/12/202323:00EDGAR2Form 8-K - Current report
06/12/202315:00EDGAR2Form RW - Registration Withdrawal Request
01/12/202315:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
28/11/202314:45EDGAR2Form 8-K - Current report
15/11/202315:00EDGAR2Form S-1 - General form for registration of securities under..
13/11/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
03/11/202321:15EDGAR2Form 8-K - Current report
19/10/202323:00EDGAR2Form 8-K - Current report
17/10/202320:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
03/10/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202314:06EDGAR2Form PRE 14A - Other preliminary proxy statements
21/9/202319:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
19/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
18/9/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/9/202322:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
Apertura: Min: Max:
Chiusura: 1,12

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network